SCHEMBL20103537

SCHEMBL20103537

C=C(CC)CCc1ccnc(CCC2CCC(c3cc(OCC)ncc3F)CC2)c1

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
LNPEP Q9UIQ6 7/20 0.32
CSF1R P07333 1/20 0.31
FFAR4 Q5NUL3 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20103371 0.80 LNPEP (0.35) LNPEP
SCHEMBL20103360 0.73 FFAR1 (0.35) FFAR4
SCHEMBL21644893 0.73 FFAR1 (0.35) FFAR4
SCHEMBL20103378 0.73 CNR2 (0.34) FFAR4
SCHEMBL20103475 0.67 FFAR1 (0.43)
SCHEMBL8216851 0.64 SLC6A2 (0.36)
SCHEMBL21644839 0.64 FFAR1 (0.54)
SCHEMBL21688291 0.64 FFAR1 (0.54)
SCHEMBL21644838 0.64 FFAR1 (0.54)
SCHEMBL20103226 0.64 FFAR1 (0.54)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018081047-A1 CYCLOHEXYL GPR40 AGONISTS FOR THE TREATMENT OF TYPE II DIABETES JANSSEN PHARMACEUTICA NV (BE) 2018-05-03 WO disclosed